Testosterone therapy in the new era of Food and Drug Administration oversight

DOI: 10.21037/tau.2016.03.13

Keywords: Hypogonadism, low testosterone, cardiovascular risk, off-label use, practice patterns, physician’s, drug prescriptions, united states food and drug administration

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text